Evoke Pharma Inc (EVOK) is around the top of the Healthcare sector according to InvestorsObserver.
EVOK received an overall rating of 82, which means that it scores higher than 82% of stocks. Additionally, Evoke Pharma Inc scored a 99 in the Healthcare sector, ranking it higher than 99% of stocks in that sector.
What do These Ratings Mean?
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 82 means the stock is more attractive than 82 percent of stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style.
Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What's Happening With Evoke Pharma Inc Stock Today?
Evoke Pharma Inc (EVOK) stock is trading at $3.72 as of 3:14 PM on Thursday, Jun 25, a gain of $0.22, or 6.28% from the previous closing price of $3.50. The stock has traded between $3.41 and $3.99 so far today. Volume today is 2,155,423 compared to average volume of 2,713,028.
